|Videos|February 15, 2016
Solving the Puzzle of High Cost Specialty Drugs
Author(s)Davy James, Managing Editor
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.
Advertisement
Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses the implications of rising drug costs on specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Role of the Pharmacist in the Management of Psychosis in Parkinson’s Disease
2
RSV Hospitalization Associated With Persistent Symptoms and Reduced Quality of Life in Adults
3
High-Fat Dairy Consumption Linked to Decreased Risk of Dementia
4
Study Links Specific Air Pollution Components to Increased Depression Risk in Older Adults
5